Consumer

TrumpRx will offer Novo Nordisk's Ozempic and Wegovy for $350 and Eli Lilly and Company's Zepbound and orforglipron, if approved by the FDA, for $346.

At Future of Health’s invitation-only event, former CDC Director Dr. Rochelle Walensky sat down with MobiHealthNews to discuss the potential and challenges of AI in healthcare.

The partnership allows Sleep Cycle users to access Dreem Health’s network of sleep specialists for evaluation and treatment of sleep disorders directly through the app.

Calm users identified as needing high-acuity mental healthcare will be connected with LifeStance’s virtual behavioral health specialists.

The tech giant launches a public preview of its personalized health coach, which helps users achieve fitness goals, analyze sleep and get answers to health questions.

The company will use the funds to grow its UK presence, expand its workforce, advance research and patient experience efforts, and enhance its data-driven care platform.

Amit Gir, CEO of Phox Health, highlights the company's partnerships with UW Medicine, Alaska Airlines and The MetroHealth System to deliver specialty medications in select states, and its plans to expand into drone-based delivery.

AI can do more than analyze data, according to the American College of Cardiology's Dr. Ami Bhatt; it can act as an adjunct to human care, boosting safety, surfacing insights and giving patients more agency.

The company's CEO, Tom Hale, told MobiHealthNews Oura will use the funds "for AI-driven innovation to redefine what digital health technology can do."

The package of bills aims to bolster protections for children using online chatbots, including prohibiting chatbots from representing themselves as healthcare professionals.